Geneious
- Company typePrivate
- Founded2004
- HeadquartersAuckland, New Zealand
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Geneious firmographics
Firmographics- Name
- Geneious
- Legal name
- GraphPad Software, LLC
- Website
- https://geneious.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Geneious industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Software Publishers (5132), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL), Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
Keywords
Where Geneious is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices1 record
Markets served
Geneious business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Subscription Licensing - Personal: Annual subscription model for individual users with tiered pricing based on user type (Student, Academic, Corporate). Includes personal cloud workspace and 10GB secure storage per user.
- Subscription Licensing - Team: Annual subscription model for groups and organizations with named user licenses, shared cloud workspace, 20GB storage per user, and enterprise features like SSO, SCIM, and audit tracking for higher tiers.
- Enterprise Licensing: Custom pricing for enterprise deployments with advanced features including one-step multiple insertion point cloning, expanded storage, public REST API, premium support, and custom invoice terms.
- Geneious Biologics Add-on: Premium add-on for antibody discovery capabilities, available as additional subscription to Geneious Prime users with cloud-based antibody screening, analysis and collaboration features.
- Geneious Luma Add-on: AI-powered scientific intelligence platform add-on for multimodal R&D, available as enterprise add-on for advanced antibody and protein engineering workflows.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Student Personal - $200/year |
| Subscription | Annual | Academic Personal - $620/year |
| Subscription | Annual | Corporate Personal - $2,150/year |
| Per seat | Annual | Academic Team - starting at $1,330/year for 2 users |
| Per seat | Annual | Corporate Team - starting at $4,700/year for 2 users |
| Subscription | Annual | Enterprise - Custom Pricing |
| Freemium | Pay-as-you-go | Free Trial - 30 days |
| Freemium | Pay-as-you-go | Geneious Biologics Free Starter |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Geneious product offering
Product offeringCore offering
Geneious develops and sells bioinformatics software for molecular biology and sequence analysis. Its core products include Geneious Prime, a desktop and cloud platform for Sanger and NGS data analysis, molecular cloning, primer design, and CRISPR; Geneious Biologics, a cloud-based antibody discovery and screening solution; and Geneious Luma, an AI-powered scientific intelligence platform for biologics R&D. The software is sold primarily on annual subscription licenses to academic, government, and biopharma customers.
Product overview
Geneious, a brand under Dotmatics, provides a portfolio of bioinformatics software products centered on molecular biology and sequence analysis. The core product is Geneious Prime, a comprehensive desktop bioinformatics platform for sequence data analysis, molecular cloning, and CRISPR tools. This integrates with Geneious Biologics, a cloud-based antibody screening and analysis solution that handles NGS, Single Cell, and Sanger datasets for antibody discovery workflows. Geneious Luma extends the portfolio with AI-powered scientific intelligence and workflow automation specifically designed for biologics R&D, connecting wet and dry lab environments. Enterprise licensing adds Single Sign-On, SCIM provisioning, and advanced automation features. Geneious Academy provides free educational resources including tutorials and video series. The products are available through personal and team subscription models for academic and corporate users.
Differentiator
Problem solved
Functional benefit
Brands
- Geneious Prime: Comprehensive suite of molecular biology and sequence analysis tools for Sanger and NGS data analysis, cloning, primer design, CRISPR, and automated workflows
- Geneious Biologics
- Geneious Luma
Products and services
- Geneious Prime Comprehensive desktop and cloud bioinformatics software providing molecular biology and sequence analysis tools including Sanger and NGS sequencing analysis, assembly, alignment, phylogenetics, molecular cloning, primer design, CRISPR tools, and automated workflows. Available for Windows, Mac, and Linux with cloud backup and collaboration features. Targeted at academic, government, and corporate researchers.
- Geneious Biologics Cloud-based antibody screening, analysis, and visualization solution for advanced analytics on NGS, Single Cell, and Sanger datasets. Provides tools for antibody sequence annotation, CDR/FR region identification, clustering, candidate selection, and high-throughput screening workflows. Targeted at biopharma and biotech antibody discovery teams.
- Geneious Luma AI-powered scientific intelligence platform for biologics R&D that unifies advanced bioinformatics and antibody discovery with AI-powered workflows. Accelerates design, analysis, and decision-making from molecular modeling to wet lab, data analysis, and registration. Targeted at biopharma enterprises developing biologics, multispecific antibodies, ADCs, CAR-T, and therapeutic proteins.
- Geneious Prime Enterprise Enterprise licensing tier for Geneious Prime providing enhanced security, collaboration, and automation features including Single Sign-On (SSO), SCIM user provisioning, audit tracking, expanded cloud storage, public REST API, one-step multiple insertion point cloning, and premium support. Targeted at large organizations with IT integration, compliance, and audit requirements.
- Geneious Biologics Free Antibody Annotator Free online tool within Geneious Biologics for annotation of IgG-like molecules. Allows upload, analysis, and visualization of individual antibody sequences with CDR/FR region identification and germline gene matching. Limited to 24 sequences at a time with 7-day result availability. Targeted at researchers exploring antibody analysis without a paid subscription.
Quantifiable outcome
- Up to 40% faster analysis on Apple Silicon (ARM64) native execution
- +1 more outcomes
Companies that use Geneious
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Geneious technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration16 records
AI capability6 records
Feature8 records
Geneious partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DotmaticsflagshipGeneious is a product under the Dotmatics scientific R&D platform. Dotmatics provides the parent infrastructure including Luma Scientific Intelligence Platform, GraphPad Prism, SnapGene, Protein Metrics, and other portfolio products. Geneious integrates with Dotmatics Bioregister for sequence registration workflows.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Geneious competitors and assessment
Company assessmentDirect peers
- SnapGene: SnapGene is a sister product under the Dotmatics portfolio focused on molecular biology procedures including cloning and sequence planning. It directly overlaps with Geneious Prime in DNA cloning and plasmid visualization, and competes for the same bench-scientist buyer.
- Benchling: Benchling is a cloud-native R&D platform serving biotech and pharma with integrated ELN, LIMS, sample tracking, and bioinformatics capabilities. It competes for the same pharma/biotech informatics buyer that Geneious targets, particularly for antibody discovery and molecular biology workflows.
- DNASTAR Lasergene: DNASTAR's Lasergene suite is a long-established desktop bioinformatics package for sequence analysis, assembly, and primer design. It is a direct competitive alternative to Geneious Prime for academic and commercial molecular biology users.
- CLC bio (Qiagen Digital Insights): Qiagen's CLC bio is a bioinformatics workbench offering sequence analysis, genomics, and metagenomics capabilities. It competes with Geneious Prime across academic, clinical research, and pharma customer segments.
- MacVector: MacVector is a macOS-native DNA and protein sequence analysis tool widely used in academic molecular biology labs. It is a direct competitor to Geneious Prime for individual bench scientists and academic core facilities.
Broad incumbents
- Genedata: Genedata provides enterprise R&D data management and analysis platforms for biopharma, including biologics discovery workflows. It is a broader incumbent that competes with Geneious Biologics and Luma for enterprise biopharma informatics budgets.
- DNAnexus: DNAnexus operates a cloud platform for genomics and biomedical data analysis used by large pharma and clinical genomics organizations. It is a broader incumbent that overlaps with Geneious in NGS data analysis and cloud bioinformatics delivery.
- Schrödinger: Schrödinger provides computational chemistry and molecular simulation software for drug discovery. It is a broader life-sciences R&D software incumbent whose biologics-focused offerings overlap with the wet-to-dry lab integration that Geneious Luma targets.
- GraphPad Prism: GraphPad Prism is another Dotmatics portfolio product focused on statistical analysis and graphing for scientists. It is a sister/adjacent offering that targets the same life-sciences researcher and competes for the same biopharma informatics wallet.
Emerging players
- LabArchives: LabArchives is an electronic lab notebook platform that integrates with bioinformatics tools and is also part of the Dotmatics portfolio. It is an emerging/adjacent player that intersects with Geneious in scientific data capture and reproducibility workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Geneious social profiles
Digital presenceGeneious compliance and trust
Trust signalCompliance2 records
Geneious financial estimates
Financial estimateRevenue estimate
Valuation estimate
Geneious leadership team
Management profileNumber of profiles
Geneious funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Geneious M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Geneious
What does Geneious do?
Geneious develops and sells bioinformatics software for molecular biology and sequence analysis. Its core products include Geneious Prime, a desktop and cloud platform for Sanger and NGS data analysis, molecular cloning, primer design, and CRISPR; Geneious Biologics, a cloud-based antibody discovery and screening solution; and Geneious Luma, an AI-powered scientific intelligence platform for biologics R&D. The software is sold primarily on annual subscription licenses to academic, government, and biopharma customers.
Is Geneious a public or private company?
Geneious is a private company. It is classified as corporate owned and is currently operating.
When was Geneious founded?
Geneious was founded in 2004. It employs 11 to 50 people.
Where is Geneious based?
Geneious is headquartered in Auckland, New Zealand, in the Oceania region.
How does Geneious make money?
Five revenue lines are on record. Subscription Licensing - Personal is the primary driver. The others are subscription Licensing - Team, enterprise Licensing, geneious Biologics Add-on and geneious Luma Add-on.
Who are Geneious's main competitors?
Direct peers on record are SnapGene, Benchling, DNASTAR Lasergene, CLC bio (Qiagen Digital Insights) and MacVector. Broad incumbents are Genedata, DNAnexus, Schrödinger and GraphPad Prism. LabArchives is listed as an emerging player.
Does Geneious have an API?
Yes. Public REST API for automating data transfer processes with secure data uploads directly into Geneious Prime. Also includes a Command Line Interface (CLI) for syncing data and running Geneious Prime operations and workflows locally or on more powerful servers. The Plugin Development Kit (PDK) allows developers to create custom plugins using the Geneious Prime API to extend functionality, integrate with existing systems, and add custom algorithms. Developer documentation is at www.geneious.com/api-developers.
What industry is Geneious in?
Geneious's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries). Its NAICS code is 5132 and its SIC code is 7372.